Align Technology (ALGN) has been beaten down lately with too much selling pressure. While the stock has lost 9.2% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than they predicted earlier.Guide to Identifying Oversold StocksWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator t ...

Align Technology’s (ALGN) robust product line, balanced growth across all channels and consistent focus on international markets to drive growth bolster our confidence in the stock. The stock carries a Zacks Rank #2 (Buy) currently.Align Technology is strategically capturing the growing malocclusion market, one of the most prevalent clinical dental conditions in the world. According to Align Technology’s 2023 data, malocclusion currently affects approximately 60% to 75% of the global population. The company ...

Is Align Technology Stock A Buy? scyther5 / Getty Images Align Technology (NASDAQ: ALGN), most notably the makers of Invisalign aligners specializes in orthodontic devices and restorative treatment has been through a whirlwind the past 2 years, with its stock price dropping 60% since its high in September 2021.2024 has also seen its challenges, after the stock increased 20% its has worked its way back down to about even for the year. For long term investors, does today’s price create a nice entry into Ali ...

Tom Werner Founded in 1997, Align Technology, Inc. (NASDAQ:ALGN) is a company that manufactures 3D digital scanners and clear aligners for teeth straightener use cases in orthodontics. ALGN went public in 2001 at a price of $17.3, and currently it is trading at $288 per share, up over 1,500% since then. However, outperformance could have been even stronger had it not been as volatile in recent times. ALGN soared to over $720 per share in 2021, but then continued its gradual decline to the current level soon ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Align Technology (ALGN) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.Align Technology is one of 1050 companies in the Medical group. The Medical group currently sits at #4 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________ FORM 10-Q ____________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-32259 ____________________________ ALIGN TECHNOLOGY, INC. (Exact name ...

Core Viewpoint - Align Technology, Inc. reported strong first-quarter fiscal 2024 results with adjusted earnings per share (EPS) of $2.14, reflecting a 17.6% increase year-over-year and exceeding estimates by 8.1% [1] Revenue Performance - Revenues for the quarter reached $997.4 million, marking a 5.8% year-over-year increase and surpassing the Zacks Consensus Estimate by 2.6% [2] - The Clear Aligner segment generated $817.3 million in revenue, up 3.5% year-over-year, driven by strong volume growth in APAC and EMEA regions [3] - Imaging Systems & CAD/CAM Services revenues increased by 2.4% to $180.2 million, impacted by unfavorable currency effects [3] Margin Analysis - Gross profit for the quarter was $697.8 million, a 5.6% increase year-over-year, with a gross margin of 70.0%, down 9 basis points from the previous year [4] - Operating income rose 15.4% to $154.1 million, with an operating margin expansion of 130 basis points to 15.5% [4] Financial Position - At the end of the first quarter, cash and cash equivalents stood at $865.8 million, down from $937.4 million at the end of the previous quarter [5] - Cumulative net cash from operating activities was $28.7 million, significantly lower than $199.9 million in the same period last year [5] Stock Repurchase Activity - In January 2024, Align Technology repurchased approximately 1.1 million shares at an average price of $230.13, with $650.0 million remaining for future repurchases [6][7] Guidance and Outlook - The company raised its full-year 2024 revenue guidance to a growth of 6-8% year-over-year, with a Zacks Consensus Estimate of $4.04 billion [8] - For Q2 2024, Align Technology anticipates revenues between $1.03 billion and $1.05 billion, aligning with the Zacks Consensus Estimate [8] Strategic Developments - Align Technology completed the acquisition of Cubicure GmbH, enhancing its capabilities in direct 3D printing solutions for aligner manufacturing [9] - The launch of the iTero Lumina intraoral scanner represents a significant advancement in digital scanning technology [9]

Financial Data and Key Metrics Changes - Total worldwide revenues for Q1 2024 were $997.4 million, up 5.8% year-over-year and up 4.3% sequentially [24][8] - Clear Aligner revenues were $817.3 million, reflecting a 3.5% year-over-year increase and a 4.5% sequential increase [24][25] - Systems and Services revenue was $180.2 million, up 17.5% year-over-year and up 3.1% sequentially [29][24] - Overall gross margin was 70%, flat sequentially and year-over-year [31][32] - Q1 net income per diluted share was $1.39, down sequentially but up $0.26 year-over-year [36] Business Line Data and Key Metrics Changes - Clear Aligner segment saw a 5.8% increase in total Invisalign case starts from teens and younger patients year-over-year [8][13] - Systems and Services revenue growth was driven by iTero Lumina wand upgrades and higher scanner volumes [9][29] - Non-case revenues for Clear Aligners increased by 7.5% year-over-year, primarily due to growth from Vivera retainers and Invisalign DSP retainer revenues [12] Market Data and Key Metrics Changes - Strong Clear Aligner volumes were primarily driven by the Asia Pacific region [8] - In the Americas region, Clear Aligner volume was consistent with the prior year [11] - Teen market saw nearly 200,000 teens starting treatment with Invisalign Clear Aligners in Q1, up 5.8% year-over-year [13] Company Strategy and Development Direction - The company completed the acquisition of Cubicure to enhance its 3D printing capabilities [9] - The launch of the iTero Lumina intraoral scanner is expected to set a new standard of care for dental practices [42] - The Invisalign Palatal Expander system is anticipated to expand the clinical applicability of the Invisalign system [43] Management's Comments on Operating Environment and Future Outlook - Management described the current business environment as stable across global markets [47][48] - The company expects Q2 2024 revenues to be in the range of $1.030 billion to $1.050 billion [39] - Fiscal 2024 total revenue is expected to increase by 6% to 8% compared to 2023, reflecting strong execution of growth strategies [40] Other Important Information - The company reported a cash balance of $902.5 million as of March 31, 2024, down sequentially [36] - Capital expenditures for Q1 were $9.4 million, primarily for increasing aligner manufacturing capacity [38] - The company plans to repurchase up to $150 million of its common stock in Q2 2024 [37] Q&A Session Summary Question: How is the overall demand environment, particularly in the U.S.? - Management described the business as stable globally, with no significant changes attributed to competitors like SmileDirectClub [46][50] Question: What is the commercialization outlook for the teen market with the new Palatal Expander? - The company believes the Palatal Expander will enhance acceptance of Phase 1 treatments among orthodontists, potentially increasing market penetration [53][55] Question: Can you elaborate on month-to-month trends in Q1? - Management noted stability throughout the quarter, with no significant month-to-month fluctuations impacting overall performance [57][58] Question: What is the expected growth for the scanner and CAD/CAM services? - The company anticipates continued double-digit growth in scanner and CAD/CAM services, driven by new product launches [62][64] Question: What percentage of cases are financed through third-party companies? - Approximately one-third of cases utilize some form of external financing, with stable lending standards reported [66][68]

For the quarter ended March 2024, Align Technology (ALGN) reported revenue of $997.43 million, up 5.8% over the same period last year. EPS came in at $2.14, compared to $1.82 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $971.97 million, representing a surprise of +2.62%. The company delivered an EPS surprise of +8.08%, with the consensus EPS estimate being $1.98.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall S ...

Align Technology (ALGN) came out with quarterly earnings of $2.14 per share, beating the Zacks Consensus Estimate of $1.98 per share. This compares to earnings of $1.82 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 8.08%. A quarter ago, it was expected that this maker of the Invisalign tooth-straightening system would post earnings of $2.18 per share when it actually produced earnings of $2.42, delivering a surprise of 11.01 ...